# SER-AP-ES
> **NDA012193** · New Drug Application · Sponsor: NOVARTIS · Approved 1960-02-11
## Drug
- **FDA Application Number:** NDA012193
- **Application type:** New Drug Application
- **Brand name:** SER-AP-ES
- **Generic name:** Hydralazine Hydrochloride
- **Active ingredients:** HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVARTIS
- **First approval:** 1960-02-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012193)
---
*MORVS · CC0 1.0*